AZNAstraZeneca PLC

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 12171
Ticker: AZN
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2009-10-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: AZN

Detail

Enriched 2026-08-14 20:47

Market cap: $245,815,405,957
Shares outstanding (class): —
Shares outstanding (weighted): 1,550,885,842
SIC: —
Employees: 96,100
Location: —
Homepage: https://www.astrazeneca.com
Description: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Market cap and share counts drift.

Funds holding this security

482 funds · 538 positions · $24.12B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	VEA	$2.84B	1.01%	14,504,632 NS	TICKER
New Perspective Fund New Perspective Fund	—	$2.73B	1.79%	13,977,931 NS	TICKER
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$2.37B	3.27%	12,021,874 NS	TICKER
EUPAC Fund EUPAC Fund	—	$2.02B	1.59%	10,349,667 NS	TICKER
American Balanced Fund American Balanced Fund	—	$595.90M	0.23%	3,050,921 NS	TICKER
WCM Focused International Growth Fund INVESTMENT MANAGERS SERIES TRUST	—	$489.69M	2.49%	2,504,260 NS	TICKER
CAUSEWAY INTERNATIONAL VALUE FUND CAUSEWAY CAPITAL MANAGEMENT TRUST	—	$477.64M	2.76%	2,442,664 NS	TICKER
VANGUARD PRIMECAP CORE FUND VANGUARD FENWAY FUNDS	—	$469.59M	3.47%	2,381,056 NS	TICKER
American Funds Fundamental Investors American Funds Fundamental Investors	—	$418.42M	0.27%	2,142,240 NS	TICKER
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$418.11M	0.32%	2,138,231 NS	TICKER
VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS	—	$417.70M	0.67%	2,117,940 NS	TICKER
International Growth and Income Fund International Growth & Income Fund	—	$379.77M	2.02%	1,944,366 NS	TICKER
New Perspective Fund New Perspective Fund	—	$363.02M	0.24%	1,840,671 NS	TICKER
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$357.97M	1.00%	1,847,882 NS	TICKER
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$345.38M	3.17%	1,751,235 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERAZN
CIK0000901832
ISINGB0009895292
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.98
Model: deepseek
Rationale: AstraZeneca is a global pharmaceutical company, so it falls under equity healthcare pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.